Further Information
IKK1, IKKA, IKBKA, TCF16, NFKBIKA, IKK-alpha, CTNNB, OK/SW-cl.35, PRO2286, I kappa-B kinase alpha, I-kappa-B kinase 1, IKK-A, IKK1
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100
Acts as part of the IKK complex in the conventional pathway of NF-κ-B activation and phosphorylates inhibitors of NF-κ-B thus leading to the dissociation of the inhibitor/NF-κ-B complex and ultimately the degradation of the inhibitor. As part of the non-canonical pathway of NF-κ-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-κ-B RelB-p52 complexes. Also phosphorylates NCOA3. Phosphorylates 'Ser-10' of histone H3 at NF-κ-B-regulated promoters during inflammatory responses triggered by cytokines.
- Yuan ZQ, et al. (2002) J Biol Chem; 277 (33): 29973-82. Ozes ON, et al. (1999) Nature; 401 (6748): 82-5.
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
1 mg/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
IKK a (Phospho-Thr23) antibody was raised against a peptide sequence around phosphorylation site of threonine 23 (L-G-T (p) -G-G) derived from Human IKK α.
Phospho-Specific
1147
conserved helix-loop-helix ubiquitous kinase
CHUK
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
85 kDa
NP_001269.3
62241001
Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Phospho-Specific,Apoptosis,Cancer
This antibody detects endogenous level of IKKα only when phosphorylated at threonine 23.
O15111